Postmenopausal Osteoporosis: The Role of Immune System Cells

Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis

(2013) Catherine MacLean et al.   ANNALS OF INTERNAL MEDICINE

TNF-α mediates the stimulation of sclerostin expression in an estrogen-deficient condition

(2012) Beom-Jun Kim et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Receptor Activator of Nuclear Factor κB Ligand (RANKL) Protein Expression by B Lymphocytes Contributes to Ovariectomy-induced Bone Loss

(2012) Melda Onal et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Análise farmacoeconômica das estratégias de tratamento da osteoporose em mulheres na pós-menopausa: uma revisão sistemática

(2012) Cristina Mariano Ruas Brandão et al.   Revista Brasileira De Reumatologia

Glucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency

(2012) Annamaria Ventura et al.   Biomed Research International

The osteoclast and its unique cytoskeleton

(2011) Steven L. Teitelbaum   Annals of the New York Academy of Sciences

A review of the efficacy and safety of denosumab in postmenopausal women with osteoporosis

(2011) Paul D. Miller   Therapeutic Advances in Musculoskeletal Disease

Denosumab and bisphosphonates: Different mechanisms of action and effects

(2010) Roland Baron et al.   BONE

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

(2010) A. Papaioannou et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Denosumab

(2010) Marit D. Moen et al.   DRUGS & AGING

Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women

(2010) Faryal S. Mirza et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Long-Term Use of Bisphosphonates in Osteoporosis

(2010) Nelson B. Watts et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bisphosphonates for Osteoporosis

(2010) Murray J. Favus   NEW ENGLAND JOURNAL OF MEDICINE

Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-α with BCAR1 and Traf6

(2009) Lisa J. Robinson et al.   EXPERIMENTAL CELL RESEARCH

Osteoclastogenesis in Children with 21-Hydroxylase Deficiency on Long-Term Glucocorticoid Therapy: The Role of Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Imbalance

(2009) Maria Felicia Faienza et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures

(2009) L. M. McNamara   Journal of the Royal Society Interface

Immune changes in post-menopausal osteoporosis: the Immunos study

(2009) V. Breuil et al.   OSTEOPOROSIS INTERNATIONAL

Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosis

(2008) Patrizia D'Amelio et al.   BONE

Bruton and Tec: New Links in Osteoimmunology

(2008) Brendan F. Boyce et al.   Cell Metabolism